68 related articles for article (PubMed ID: 21226699)
1. Thrombolysis in very old people with stroke: stroke subtypes, patterns, complications, and clinical outcome.
Förster A; Szabo K; Kreisel S; Shah YP; Kern R; Griebe M; Hennerici MG
J Am Geriatr Soc; 2011 Jan; 59(1):178-80. PubMed ID: 21226699
[No Abstract] [Full Text] [Related]
2. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
3. Thrombolysis for stroke in the over 80s.
Ford GA
Age Ageing; 2004 Mar; 33(2):95-7. PubMed ID: 14960420
[No Abstract] [Full Text] [Related]
4. Intravenous thrombolysis is feasible and safe in multiethnic Asian stroke patients in Singapore.
Sharma VK; Tsivgoulis G; Tan JH; Ong BK; Chan BP; Teoh HL
Int J Stroke; 2009 Oct; 4(5):320-1. PubMed ID: 19765117
[No Abstract] [Full Text] [Related]
5. Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience.
Simon JE; Sandler DL; Pexman JH; Hill MD; Buchan AM;
Age Ageing; 2004 Mar; 33(2):143-9. PubMed ID: 14960429
[TBL] [Abstract][Full Text] [Related]
6. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
7. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.
Sobesky J; Frackowiak M; Zaro Weber O; Hahn M; Möller-Hartmann W; Rudolf J; Neveling M; Grond M; Schmulling S; Jacobs A; Heiss WD
Cerebrovasc Dis; 2007; 24(1):56-65. PubMed ID: 17519545
[TBL] [Abstract][Full Text] [Related]
8. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
9. Thrombolysis for stroke: policy should be based on science, and not on politics, money or fear of malpractice.
Hoffman JR
Emerg Med Australas; 2006 Jun; 18(3):215-8. PubMed ID: 16712529
[No Abstract] [Full Text] [Related]
10. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
11. Systemic thrombolysis in ischemic stroke after recent oral surgery and management of oral cavity bleeding.
Seifert CL; Sprenger T; Mücke T; Foerschler A; Poppert H; Hemmer B; Sellner J
Ann Emerg Med; 2011 May; 57(5):517-9. PubMed ID: 21227542
[TBL] [Abstract][Full Text] [Related]
12. Life after SAINT.
Hallevi H; Aronowski J
Int J Stroke; 2007 Nov; 2(4):241-2. PubMed ID: 18705923
[No Abstract] [Full Text] [Related]
13. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke.
Caplan LR; Mohr JP; Kistler JP; Koroshetz W
N Engl J Med; 1997 Oct; 337(18):1309-10; discussion 1313. PubMed ID: 9345084
[No Abstract] [Full Text] [Related]
14. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G
Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954
[TBL] [Abstract][Full Text] [Related]
15. Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample.
Dubinsky R; Lai SM
Neurology; 2006 Jun; 66(11):1742-4. PubMed ID: 16769953
[TBL] [Abstract][Full Text] [Related]
16. Systemic thrombolysis with rt-PA in patients under 40 years of age: a subgroup analysis of the Cologne Stroke Experience.
Galldiks N; Zaro-Weber O; Dohmen C; Neveling M; Haupt WF; Fink GR; Sobesky J
Cerebrovasc Dis; 2010; 30(5):514-8. PubMed ID: 20861623
[TBL] [Abstract][Full Text] [Related]
17. Safety and outcome after thrombolysis in stroke patients with mild symptoms.
Köhrmann M; Nowe T; Huttner HB; Engelhorn T; Struffert T; Kollmar R; Saake M; Doerfler A; Schwab S; Schellinger PD
Cerebrovasc Dis; 2009; 27(2):160-6. PubMed ID: 19092237
[TBL] [Abstract][Full Text] [Related]
18. Twelve-month experience of acute stroke thrombolysis in Christchurch, New Zealand: emergency department screening and acute stroke service treatment.
Fink J
N Z Med J; 2005 May; 118(1214):U1430. PubMed ID: 15886726
[TBL] [Abstract][Full Text] [Related]
19. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
[TBL] [Abstract][Full Text] [Related]
20. Clinical, biochemical and neuroimaging parameters after thrombolytic therapy predict long-term stroke outcome.
Brouns R; Sheorajpanday R; Kunnen J; De Surgeloose D; De Deyn PP
Eur Neurol; 2009; 62(1):9-15. PubMed ID: 19407450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
